P2.16-06 Development and Validation of a Gene Expression-Based Nomogram to Predict Relapse in Stage I NSCLC: A Retrospective, Multi-Cohort Study

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1481
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.01-74 Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Development and Validation of a Robust Multigene Signature as an Aid to Predict Early Relapse in Stage I-Iii Clear Cell and Papillary Renal Cell Cancer

Journal of Cancer
Oncology
2020English

P2.16-49 Which Nomogram Is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Development and Validation of a Nomogram to Predict Survival in Incurable Cachectic Cancer Patients on Home Parenteral Nutrition

Annals of Oncology
MedicineOncologyHematology
2015English

P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients With Peripheral Stage I NSCLC Considered to Be at Higher Risk for Surgery

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.16-24 Racial Differences in Treatment and Survival of Stage I NSCLC: A Comparison of Veterans Affairs (VA) and SEER-Medicare Populations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

Clinical Cancer Research
Cancer ResearchOncology
2007English

Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation Within a Population Based Cohort

Clinical Cancer Research
Cancer ResearchOncology
2019English

P2.13-27 Development, Internal Validation, and Calibration of a Risk Score to Predict Survival in Patients With EGFR Mutant NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy